BDBM66263 2-[4-[2-(2-chloroanilino)-2-keto-ethyl]piperazino]-N-(3-chloro-4-methoxy-phenyl)acetamide::2-[4-[2-(2-chloroanilino)-2-oxoethyl]-1-piperazinyl]-N-(3-chloro-4-methoxyphenyl)acetamide::2-[4-[2-(2-chloroanilino)-2-oxoethyl]piperazin-1-yl]-N-(3-chloro-4-methoxyphenyl)acetamide::MLS000047473::N-(3-chloranyl-4-methoxy-phenyl)-2-[4-[2-[(2-chlorophenyl)amino]-2-oxidanylidene-ethyl]piperazin-1-yl]ethanamide::SMR000033484::cid_3241535

SMILES COc1ccc(NC(=O)CN2CCN(CC(=O)Nc3ccccc3Cl)CC2)cc1Cl

InChI Key InChIKey=CSWNAIQISZHXCX-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 66263   

TargetTransient receptor potential cation channel subfamily M member 3(Mouse)
Katholieke Universiteit Leuven

US Patent
LigandChemical structure of BindingDB Monomer ID 66263BDBM66263(US12209081, Compound 435-En-1)
Affinity DataIC50: 1.00E+3nMAssay Description:Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute (TS...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/5/2026
Entry Details US Patent